These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30900171)

  • 21. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.
    Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK
    Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health problems in females carriers of premutation in the FMR1 gene.
    Lisik MZ
    Psychiatr Pol; 2017 Oct; 51(5):899-907. PubMed ID: 29289969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
    Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
    Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The fragile x-associated tremor and ataxia syndrome (FXTAS).
    Capelli LP; Gonçalves MR; Leite CC; Barbosa ER; Nitrini R; Vianna-Morgante AM
    Arq Neuropsiquiatr; 2010 Oct; 68(5):791-8. PubMed ID: 21049196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array.
    Schenkel LC; Schwartz C; Skinner C; Rodenhiser DI; Ainsworth PJ; Pare G; Sadikovic B
    J Mol Diagn; 2016 Nov; 18(6):834-841. PubMed ID: 27585064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Fragile X premutation: new insights and clinical consequences.
    Van Esch H
    Eur J Med Genet; 2006; 49(1):1-8. PubMed ID: 16473304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting AGG Interruptions in Male and Female FMR1 Premutation Carriers by Single-Molecule Sequencing.
    Ardui S; Race V; Zablotskaya A; Hestand MS; Van Esch H; Devriendt K; Matthijs G; Vermeesch JR
    Hum Mutat; 2017 Mar; 38(3):324-331. PubMed ID: 27883256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic testing in fragile X syndrome].
    Sireteanu A; Rusu C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):968-71. PubMed ID: 17438909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for FXTAS in 95 Spanish patients negative for Huntington disease.
    Rodriguez-Revenga L; Santos MM; Sánchez A; Pujol M; Gómez-Anson B; Badenas C; Jiménez D; Madrigal I; Milà M
    Genet Test; 2008 Mar; 12(1):135-8. PubMed ID: 18373410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simplified strategy for rapid first-line screening of fragile X syndrome: closed-tube triplet-primed PCR and amplicon melt peak analysis.
    Rajan-Babu IS; Law HY; Yoon CS; Lee CG; Chong SS
    Expert Rev Mol Med; 2015 May; 17():e7. PubMed ID: 25936533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetics of fragile X syndrome and fragile X-related disorders.
    Kraan CM; Godler DE; Amor DJ
    Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of Fragile X syndrome.
    Basehore MJ; Friez MJ
    Curr Protoc Hum Genet; 2009 Oct; Chapter 9():Unit 9.5. PubMed ID: 19806593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients.
    Esanov R; Andrade NS; Bennison S; Wahlestedt C; Zeier Z
    Hum Mol Genet; 2016 Nov; 25(22):4870-4880. PubMed ID: 28173181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current controversies in prenatal diagnosis 1: screening for fragile X syndrome.
    Yaron Y; Musci T; Cuckle H
    Prenat Diagn; 2013 Jan; 33(1):6-8. PubMed ID: 23079963
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular testing for Fragile X Syndrome: lessons learned from 119,232 tests performed in a clinical laboratory.
    Strom CM; Crossley B; Redman JB; Buller A; Quan F; Peng M; McGinnis M; Fenwick RG; Sun W
    Genet Med; 2007 Jan; 9(1):46-51. PubMed ID: 17224689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.
    Lozano R; Martinez-Cerdeno V; Hagerman RJ
    Curr Pharm Des; 2015; 21(34):4972-4979. PubMed ID: 26365141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexistence of Fragile-X Syndrome, 8p23.1 Deletion, and Balanced Translocation t(7;10)(p10;q24) in a Single Family.
    Cortés H; Reyes-Rosales M; Rojas-Velasco AJ; García-Juárez B; Tapia-Guerrero YS; Arenas-Diaz S; Leyva-García N; Macías-Gallardo JJ; Carrillo-Mora P; Magaña JJ
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):527-531. PubMed ID: 32716213
    [No Abstract]   [Full Text] [Related]  

  • 38. Simple molecular diagnostic method for fragile X syndrome in Egyptian patients: pilot study.
    Meguid NA; Ismail MF; El-Mahdy RS; Barakat MA; El-Awady MK
    Acta Biochim Pol; 2014; 61(2):259-63. PubMed ID: 24936518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The FMR1 premutation and reproduction.
    Wittenberger MD; Hagerman RJ; Sherman SL; McConkie-Rosell A; Welt CK; Rebar RW; Corrigan EC; Simpson JL; Nelson LM
    Fertil Steril; 2007 Mar; 87(3):456-65. PubMed ID: 17074338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Premutations in the FMR1 gene are uncommon in men undergoing genetic testing for spinocerebellar ataxia.
    Adams SA; Steenblock KJ; Thibodeau SN; Lindor NM
    J Neurogenet; 2008; 22(1):77-92. PubMed ID: 18363164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.